[1]
“NEUROINFLAMMATION IN ALZHEIMER’S DISEASE AND INVOLVEMENT OF INTERLEUKIN-1: A MECHANISTIC VIEW”, Int. J. Pharm. Sci. Drug Res., vol. 3, no. 4, pp. 287–291, Oct. 2011, doi: 10.25004/IJPSDR.2011.030403.